Section III
131 – 140 of 6856
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Illuminating the Invisible: Green Fluorescent Protein as a Beacon for Antibiotic-Induced Phage Activity in
Escherichia coli.
(
- Contribution to journal › Article
-
Mark
Aerosolized Dornase Alfa (DNase I) for the Treatment of Severe Respiratory Failure in COVID-19 : A Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Response to Letter to the Editor from Candemir and Çakal : "24-Hour Urine Calcium Predicts Reduced Fracture Incidence and Improved Bone Mineral Density after Surgery for Primary Hyperparathyroidism"
(
- Contribution to journal › Letter
-
Mark
Contributions of injury deaths to changes in life expectancy and disparity : A comparative analysis of G7 countries over two decades
(
- Contribution to journal › Article
-
Mark
Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol
(
- Contribution to journal › Article
-
Mark
Infectivity of exhaled SARS-CoV-2 aerosols is sufficient to transmit covid-19 within minutes
(
- Contribution to conference › Abstract
-
Mark
Exhaled particles and viruses from humans
(
- Contribution to conference › Abstract
-
Mark
Risk-based ventilation of patient rooms in hospitals, and its costs : is the ventilation worth the price?
(
- Contribution to conference › Abstract
-
Mark
Comparison of airborne SARS-CoV-2 Omicron and pre-Delta variants around infected patients
(
- Contribution to conference › Abstract
-
Mark
Airborne SARS-CoV-2 in healthcare settings : when, where and how to prevent it?
(
- Contribution to conference › Abstract